Ftse Mib
32.908,05
0,74%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
66.472,92
-0,25%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ RenovoRx Inc (RNXT) RenovoRx Inc (RNXT) Notizie

RNXT

RenovoRx (RNXT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNXT
DataOraFonteTitoloSimboloCompagnia
10/06/202414:30GlobeNewswire Inc.RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and PartnershipsNASDAQ:RNXTRenovoRx Inc
07/06/202422:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
30/05/202414:30Business WireRenovoRx CEO Issues Update Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
21/05/202415:00Business WirePublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryNASDAQ:RNXTRenovoRx Inc
14/05/202415:00Business WireRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024NASDAQ:RNXTRenovoRx Inc
13/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
10/05/202423:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
10/05/202422:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
02/05/202415:00Business WireRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024NASDAQ:RNXTRenovoRx Inc
18/04/202414:30Business WireRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity RequirementNASDAQ:RNXTRenovoRx Inc
16/04/202414:30Business WireRenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingNASDAQ:RNXTRenovoRx Inc
15/04/202414:00Business WireRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026NASDAQ:RNXTRenovoRx Inc
08/04/202414:30Business WireRenovoRx Announces $11.1 Million at Market Private PlacementNASDAQ:RNXTRenovoRx Inc
05/04/202414:30Business WireRenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024NASDAQ:RNXTRenovoRx Inc
12/03/202414:00Business WireRenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024NASDAQ:RNXTRenovoRx Inc
08/03/202422:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202422:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202422:05Business WireRenovoRx Highlights Key Leadership PromotionsNASDAQ:RNXTRenovoRx Inc
09/02/202422:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RNXTRenovoRx Inc
06/02/202414:30Business WireRenovoRx CEO Issues Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
29/01/202414:30Business WireRenovoRx Closes $6.1 Million Private PlacementNASDAQ:RNXTRenovoRx Inc
21/12/202314:30Business WireRenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct CancerNASDAQ:RNXTRenovoRx Inc
19/12/202314:30Business WireRenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingNASDAQ:RNXTRenovoRx Inc
13/12/202314:31Business WireRenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy PlatformNASDAQ:RNXTRenovoRx Inc
27/11/202319:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RNXTRenovoRx Inc
17/11/202323:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RNXTRenovoRx Inc
16/11/202314:35Business WireRenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.NASDAQ:RNXTRenovoRx Inc
14/11/202314:30Business WireRenovoRx Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:RNXTRenovoRx Inc
02/10/202314:30Business WireRenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023NASDAQ:RNXTRenovoRx Inc
17/08/202314:30Business WireRenovoRx Reports Second Quarter 2023 Financial Results and Operational HighlightsNASDAQ:RNXTRenovoRx Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNXT

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network